SCHEMBL17431884

SCHEMBL17431884

COc1cccc(OC(C)C)c1-c1ccc(-c2cc3sc(-c4c(OC)cccc4OC(C)C)cc3s2)s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 1/20 0.38
▸ EGFR P00533 2/20 0.37
▸ MCHR1 Q99705 1/20 0.35
▸ CTSA P10619 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ AURKA O14965 1/20 0.34
▸ CSF1R P07333 1/20 0.34
▸ RET P07949 1/20 0.34
▸ FLT3 P36888 1/20 0.34
▸ CA2 P00918 2/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA7 P43166 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ THRB P10828 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ MAPK3 P27361 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ MAP2K1 Q02750 1/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14225424 0.93 EGFR (0.40) APPEGFRMCHR1CTSANPSR1
SCHEMBL19521918 0.90 APP (0.46) APPEGFRMCHR1CTSANPSR1
SCHEMBL14225418 0.90 APP (0.46) APPEGFRMCHR1CTSANPSR1
SCHEMBL14225431 0.90 APP (0.46) APPEGFRMCHR1CTSANPSR1
SCHEMBL14225415 0.88 APP (0.47) APPEGFRMCHR1CTSANPSR1
SCHEMBL10054562 0.83 EGFR (0.38) APPEGFRMCHR1CTSANPSR1
SCHEMBL14225439 0.81 APP (0.43) APPEGFRMCHR1CTSANPSR1
SCHEMBL14225426 0.80 EGFR (0.39) APPEGFRMCHR1CTSANPSR1
SCHEMBL17431908 0.78 APP (0.57) APPMCHR1AURKACSF1RRET
SCHEMBL14225422 0.77 EGFR (0.38) APPEGFRMCHR1CTSANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9969931-B2 Electrochromic composition and electrochromic element CANON KABUSHIKI KAISHA (JP) 2018-05-15 — — US disclosed
US-9969931-B2 Electrochromic composition and electrochromic element CANON KABUSHIKI KAISHA (JP) 2018-05-15 — — US disclosed
US-20170114274-A1 ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT CANON KABUSHIKI KAISHA (JP) 2017-04-27 — — US disclosed
US-20170114274-A1 ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT CANON KABUSHIKI KAISHA (JP) 2017-04-27 — — US disclosed
WO-2016006204-A1 ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT CANON KABUSHIKI KAISHA (JP) 2016-01-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170114274-A1 ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT SCN11A, ECH1, H1-0 APP 2275/4885EGFR 1045/4885MCHR1 1182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback